相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury
Felix Poppelaars et al.
FASEB JOURNAL (2017)
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Niels C. Riedemann et al.
CLINICAL IMMUNOLOGY (2017)
Terminal complexes of the complement system: new structural insights and their relevance to function
Bryan Paul Morgan et al.
IMMUNOLOGICAL REVIEWS (2016)
Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling
Daniel E. Croker et al.
IMMUNOLOGY AND CELL BIOLOGY (2016)
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease
Christine Landlinger et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedule
Philippe Gatault et al.
MABS (2015)
High Expression of C5L2 Correlates with High Proinflammatory Cytokine Expression in Advanced Human Atherosclerotic Plaques
Santosh Vijayan et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
C5L2 is required for C5a-triggered receptor internalization and ERK signaling
Wei-Chan Hsu et al.
CELLULAR SIGNALLING (2014)
Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model
C. Andersson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment
Daniel E. Croker et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma
Elizabeth B. Staab et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Hong Xiao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Structural and functional characterization of human and murine C5a anaphylatoxins
Janus Asbjorn Schatz-Jakobsen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2014)
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
Peter Hillmen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Extracellular histones are essential effectors of C5aR-and C5L2-mediated tissue damage and inflammation in acute lung injury
Markus Bosmann et al.
FASEB JOURNAL (2013)
Disruption of the Complement Anaphylatoxin Receptor C5L2 Exacerbates Inflammation in Allergic Contact Dermatitis
Ruobing Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
A Pro-Inflammatory Role of C5L2 in C5a-Primed Neutrophils for ANCA-Induced Activation
Jian Hao et al.
PLOS ONE (2013)
International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors
Andreas Klos et al.
PHARMACOLOGICAL REVIEWS (2013)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Membrane attack by complement: the assembly and biology of terminal complement complexes
Cosmin A. Tegla et al.
IMMUNOLOGIC RESEARCH (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a
Hydar Ali
IMMUNOLOGY LETTERS (2010)
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction
Claire E. Bamberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Critical Role for C5L2 in the Pathogenesis of Experimental Allergic Asthma
Xun Zhang et al.
JOURNAL OF IMMUNOLOGY (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
Kutty Selva Nandakumar et al.
PLOS ONE (2010)
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism
Claire L. Dobson et al.
MABS (2009)
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
C. Lloyd et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Functional roles for C5a receptors in sepsis
Daniel Rittirsch et al.
NATURE MEDICINE (2008)
The role of the complement anaphylatoxins in the recruitment of eosinophils
Richard G. DiScipio et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
Function, structure and therapeutic potential of complement C5a receptors
P. N. Monk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
Nien-Jung Chen et al.
NATURE (2007)
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding
Anne-Marie Scola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Antibody therapeutics: isotype and glycoform selection
Roy Jefferis
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Affinity maturation of phage display antibody populations using ribosome display
Maria Groves et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
The integration of macromolecular diffraction data
AGW Leslie
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Scaling and assessment of data quality
P Evans
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2
NP Gerard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A Tn7-based broad-range bacterial cloning and expression system
KH Choi et al.
NATURE METHODS (2005)
Likelihood-enhanced fast translation functions
AJ McCoy et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Likelihood-enhanced fast rotation functions
LC Storoni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2 -: Position 69 is the locus that determines agonism or antagonism
M Otto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Carboxypeptidase N: a pleiotropic regulator of inflammation
KW Matthews et al.
MOLECULAR IMMUNOLOGY (2004)
Formation of high affinity C5 convertase of the classical pathway of complement
N Rawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage
M Fung et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Structure-function relationships of human C5a and C5aR
MS Huber-Lang et al.
JOURNAL OF IMMUNOLOGY (2003)
Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity
M Drogari-Apiranthitou et al.
INFECTION AND IMMUNITY (2002)
The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)
SA Cain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells
M Ohno et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
